Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2026)

Rhythm Pharmaceuticals (RYTM) has 4 years of Inventory Average data on file, last reported at $27.2 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 42.95% year-over-year to $27.2 million in Q1 2026; TTM through Mar 2026 was $27.2 million, a 42.95% increase from a year earlier, with the FY2025 full-year figure at $22.2 million, up 62.59% from the prior year.
• Inventory Average for Q1 2026 stood at $27.2 million, up from $23.9 million in the prior quarter.
• Over the last five years, Inventory Average for RYTM reached as high as $27.2 million in Q1 2026 and fell as low as $4.2 million in Q1 2023.
• Historically, Inventory Average has averaged $14.1 million across 4 years, with a median of $12.9 million in 2024.
• Across the five-year window, Inventory Average jumped 122.15% in 2025 and jumped 42.95% in 2026, its largest moves.
• Year by year, Inventory Average stood at $8.2 million in 2023, then soared by 99.17% to $16.3 million in 2024, then surged by 46.65% to $23.9 million in 2025, then rose by 13.67% to $27.2 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $27.2 million in Q1 2026, $23.9 million in Q4 2025, and $20.5 million in Q3 2025.